LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

businesswire

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE) – NEWSnet – News… as it used to be

More Press Releases

May 30, 2026

Ducks Unlimited Completes Historic $4.06 Billion Campaign

May 30, 2026

Certified Auto Repair Experts Note Market Effects of Proposed E.U. Auto Tariffs

May 30, 2026

Keller ISD Expands Student Access to Keyboarding Curriculum

May 30, 2026

LEO Pharma Presents Late-Breaking Phase 3 Delgocitinib Cream Data in Adolescents with Moderate to Severe Chronic Hand Eczema (CHE)

Ducks Unlimited Completes Historic $4.06 Billion Campaign

Certified Auto Repair Experts Note Market Effects of Proposed E.U. Auto Tariffs

Keller ISD Expands Student Access to Keyboarding Curriculum

Certified Camper Sales Rise Ahead of Summer Travel Season